Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Stocks
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
2026-08-21
|
5-day change | 1st Jan Change | ||
| 35.35 CNY | -2.56% |
|
-2.27% | -22.51% |
| Market Cap | 23.59B 3.51B 3.01B 2.81B 2.58B 4.83B 336B 4.9B 33.24B 12.96B 169B 13.18B 12.89B 558B | P/E 2026 * |
26.4x | P/E 2027 * | 23x |
|---|---|---|---|---|---|
| Enterprise Value | 23.59B 3.51B 3.01B 2.81B 2.58B 4.83B 336B 4.9B 33.24B 12.96B 169B 13.18B 12.89B 558B | EV / Sales 2026 * |
4.78x | EV / Sales 2027 * | 4.41x |
| Free-Float |
31.71% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.56% | ||
| 1 week | -2.27% | ||
| Current month | -7.68% | ||
| 1 month | -7.24% | ||
| 3 months | -14.72% | ||
| 6 months | -18.15% | ||
| Current year | -22.51% |
| 1 week | 35.12 |  | 36.46 |
| 1 month | 35.12 | | 38.92 |
| Current year | 34.7 | | 48.2 |
| 1 year | 34.7 | | 50.95 |
| 3 years | 23.4 | | 50.97 |
| 5 years | 17.98 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 55 | 2017-10-09 |
Hong Zhou
PRN | Corporate Officer/Principal | 56 | - |
Mai Wang
PRN | Corporate Officer/Principal | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Xiu Mei Guo
BRD | Director/Board Member | 44 | 2018-12-23 |
Mai Wang
BRD | Director/Board Member | 56 | - |
Hong Zhou
BRD | Director/Board Member | 56 | 2019-05-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.56% | -2.27% | -23.52% | +0.40% | 3.51B | |
| -1.75% | -1.40% | -14.21% | -5.61% | 13.09B | |
| -2.74% | -2.90% | -36.07% | -57.12% | 4.85B | |
| -6.30% | -6.88% | -5.44% | -5.58% | 4.59B | |
| -5.35% | -3.01% | +1.54% | -29.16% | 4.09B | |
| -2.87% | -0.49% | -11.66% | -8.00% | 3.34B | |
| -3.23% | -2.35% | -13.02% | +10.97% | 3.33B | |
| -4.14% | -2.45% | -19.04% | -16.78% | 2.43B | |
| -3.92% | -3.50% | -29.67% | -14.73% | 1.67B | |
| -4.21% | -10.00% | -7.69% | -15.79% | 1.63B | |
| Average | -3.71% | -3.43% | -15.88% | -14.14% | 4.25B | |
| Weighted average by Cap. | -3.29% | -2.64% | -15.35% | -13.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.93B 734M 628M 588M 538M 1.01B 70.18B 1.02B 6.95B 2.71B 35.26B 2.75B 2.69B 117B | 5.35B 796M 682M 638M 584M 1.1B 76.16B 1.11B 7.54B 2.94B 38.26B 2.99B 2.92B 127B |
| Net income | 1.04B 154M 132M 124M 113M 212M 14.75B 215M 1.46B 569M 7.41B 579M 566M 24.5B | 1.18B 176M 151M 141M 129M 243M 16.85B 246M 1.67B 650M 8.47B 661M 647M 28B |
| Net Debt | - | - |
Employees
3,890
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | CN¥35.35 | -2.56% | 3,129,900 |
| 26-08-20 | CN¥36.28 | +1.77% | 3,177,569 |
| 26-08-19 | CN¥35.65 | -0.59% | 2,503,921 |
| 26-08-18 | CN¥35.86 | -0.83% | 2,168,810 |
| 26-08-17 | CN¥36.16 | -0.03% | 3,733,271 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
35.35
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
